East Norriton, Penn., Aug. 3, 2015. TGaS® Advisors has expanded its life sciences commercial services with the addition of TGaS InsightsTM, making the firm’s benchmark and advisory findings more broadly available in new, user friendly formats. Tim Wohlgemut leads the new area.
TGaS Insights leverages the firm’s decade long body of knowledge and experience to provide pharmaceutical and emerging life sciences leaders with a portfolio of products and tools, reports and resources designed to make the data and intelligence of TGaS Advisors readily available to pharmaceutical executives.
Wohlgemut, Senior Vice President for TGaS Insights and a member of the TGaS Executive Leadership Team, is responsible for developing the new offering: “TGaS Insights is designed to help our clients anticipate and overcome challenges, make better decisions faster and accelerate commercial success.”
He cites RAPiD, a new Resource Assessment & Planning Diagnostic, as an example. One of the first offerings of the new service, RAPiD is designed to streamline the annual planning process by providing a fact-based, objective assessment outlining headcount and spending by function compared to peer benchmarks. “The Diagnostic is intended to reduce the time and resources needed to finalize the budget and increase the likelihood that it supports company goals,” he said.
Prior to joining TGaS, Wohlgemut was CoPresident of Millennium Research Group (MRG), a leading market research firm focused on the medical device industry. He has also headed research, sales, marketing and operations divisions at MRG and served on the executive board of the firm’s parent company, Decision Resources Group. Most recently, Wohlgemut was founder and CEO of ClearSky Advisors, a leading market research firm focused on the energy industry. He is a graduate of the University of Waterloo, Ontario, Canada.
For more information on TGaS Insights, contact Tim.Wohlgemut@tgas.com.
About TGaS® Advisors
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. With a roster of top 50, emerging and precommercial pharmaceutical companies, TGaS provides robust comparative intelligence and collaborative network membership services. Clients can access the TGaS network, database and industry experts to establish and improve commercial effectiveness and demonstrate their impact on business results. TGaS Advisors is based in East Norriton, Penn. To learn more, visit www.tgas.com.
Help employers find you! Check out all the jobs and post your resume.
TGaS Insights leverages the firm’s decade long body of knowledge and experience to provide pharmaceutical and emerging life sciences leaders with a portfolio of products and tools, reports and resources designed to make the data and intelligence of TGaS Advisors readily available to pharmaceutical executives.
Wohlgemut, Senior Vice President for TGaS Insights and a member of the TGaS Executive Leadership Team, is responsible for developing the new offering: “TGaS Insights is designed to help our clients anticipate and overcome challenges, make better decisions faster and accelerate commercial success.”
He cites RAPiD, a new Resource Assessment & Planning Diagnostic, as an example. One of the first offerings of the new service, RAPiD is designed to streamline the annual planning process by providing a fact-based, objective assessment outlining headcount and spending by function compared to peer benchmarks. “The Diagnostic is intended to reduce the time and resources needed to finalize the budget and increase the likelihood that it supports company goals,” he said.
Prior to joining TGaS, Wohlgemut was CoPresident of Millennium Research Group (MRG), a leading market research firm focused on the medical device industry. He has also headed research, sales, marketing and operations divisions at MRG and served on the executive board of the firm’s parent company, Decision Resources Group. Most recently, Wohlgemut was founder and CEO of ClearSky Advisors, a leading market research firm focused on the energy industry. He is a graduate of the University of Waterloo, Ontario, Canada.
For more information on TGaS Insights, contact Tim.Wohlgemut@tgas.com.
About TGaS® Advisors
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. With a roster of top 50, emerging and precommercial pharmaceutical companies, TGaS provides robust comparative intelligence and collaborative network membership services. Clients can access the TGaS network, database and industry experts to establish and improve commercial effectiveness and demonstrate their impact on business results. TGaS Advisors is based in East Norriton, Penn. To learn more, visit www.tgas.com.
Help employers find you! Check out all the jobs and post your resume.
